People who received a flu shot last flu season were significantly less likely to test positive for a COVID-19 infection when the pandemic hit, according to a new study. And those who did test positive for COVID-19 had fewer complications if they received their flu shot.
UC San Diego School of Medicine researchers develop an automated process to test city sewage for SARS-CoV-2, allowing them to forecast the region’s COVID-19 caseload one to two weeks ahead of clinical diagnostic reports.
An essential strategy for managing COVID-19 requires vast amounts of real-world data to enable researchers to find patterns that will help to better understand and manage this disease. Florida Atlantic University has launched a registry and repository to contribute to new discoveries and knowledge related to COVID-19 and is currently enrolling study participants.
A new therapy developed by researchers at Rush University Medical Center is showing success as a way to prevent COVID-19 symptoms in mice.
Ali Gholamrezanezhad, MD, a clinical emergency radiologist with Keck Medicine of USC, was one of the first researchers to study COVID-19 in early 2020. Today, Gholamrezanezhad has co-authored more than 40 papers on the disease, gathering and analyzing a wide array of data and patient scans. He offers his unique insights into a virus that has infected more than 43 million people worldwide.
UC San Diego Health will be part of the Phase III national AstraZeneca clinical trial that will recruit up to 30,000 participants at multiple sites across the country to assess the safety and efficacy of a vaccine to prevent COVID-19.
Thomas Jefferson University Awarded $508,000 by the Commonwealth to support CoraVax™, a patented COVID-19 vaccine
A recent study by researchers at University of California San Diego School of Medicine suggests transmission of COVID-19 through breast milk is not likely. The infectious virus was not detected in 64 samples of breast milk tested.
The National Institutes of Health will soon launch a phase II clinical trial to evaluate the safety and efficacy of potential new therapeutics for COVID-19, including the use of investigational synthetic monoclonal antibodies. Davey Smith of UC San Diego is the protocol chair and answers questions.
The AIDS Clinical Trials Group (ACTG) has initiated the ACTIV-2 Outpatient Monoclonal Antibodies and Other Therapies Trial. ACTIV-2 includes both phase 2 and phase 3 evaluations of multiple promising investigational agents for treating early COVID-19 in a single trial.
In response to the COVID-19 pandemic, DePaul University has called on its scientific community to address challenges in the areas of disease dynamics, health diagnostics, security, preparation for testing, and clinical care related to the outbreak.
As we continue to grapple with the global pandemic, rising summer temperatures and wildfire season pose new challenges to our lung health. A team of pulmonologists and researchers at UC San Diego Health offer a wide variety of expertise and…
Researchers at University of California San Diego School of Medicine and UC San Diego Health have launched a clinical trial to assess the safety and efficacy of convalescent plasma (CP) to prevent COVID-19 after a known exposure to the virus.
During the novel coronavirus pandemic, many couples have concerns about reproductive consequences related to COVID-19. Experts say when it comes to the impact of infections similar to coronavirus — such as influenza — on female and male fertility, the evidence…
Researchers have performed the first room temperature X-ray measurements on the SARS-CoV-2 main protease—the enzyme that enables the virus to reproduce. It marks an important first step in the ultimate goal of building a comprehensive 3D model of the enzymatic protein that will be used to advance supercomputing simulations aimed at finding drug inhibitors to block the virus’s replication mechanism and help end the COVID-19 pandemic.
Cleveland Clinic researchers have developed the world’s first risk prediction model for healthcare providers to forecast an individual patient’s likelihood of testing positive for COVID-19 as well as their outcomes from the disease.
According a new study published in CHEST, the risk prediction model (called a nomogram) shows the relevance of age, race, gender, socioeconomic status, vaccination history and current medications in COVID-19 risk.
Can art help doctors better understand their patients and address racial disparities? An innovative collaboration at the University of Alabama at Birmingham uses art to help medical students hone their observational skills, in order to make more accurate diagnoses. “Prescribing Art: How Observation Enhances Medicine” is a partnership between the School of Medicine, the Abroms-Engel Institute for Visual Arts and the Birmingham Civil Rights Institute.
In a perspective piece published today in the journal Science, UC San Diego experts describe in detail the growing evidence that SARS-CoV-2, the novel coronavirus that causes COVID-19, can be spread by asymptomatic people via aerosols — a reality that…
The first convalescent plasma transfusion trial results from Houston Methodist have been released. Of the 25 patients in the study, 19 have improved and 11 have been discharged. With no adverse side effects caused by the therapy, the study concluded that convalescent plasma is a safe treatment option for patients with severe COVID-19. This is the largest cohort assessed for outcomes related to convalescent plasma therapy for COVID-19.
UC San Diego Health now offers a telemedicine clinic to help patients with COVID-19 recover at home.
UC San Diego Health has launched a Phase III clinical trial to assess whether a medication used to treat rheumatoid might also have therapeutic value for patient with COVID-19 who have developed or are at high risk of developing serious lung damage from SARS-CoV-2 infections.
Necessity being the mother of invention, Houston Methodist clinicians, researchers and staff have collaborated on a number of clinical device and research innovations in response to COVID-19. Houston Methodist Academic Institute leadership has continually emphasized translational research in new technologies.
Researchers at UC San Diego Health report in newly published findings that olfactory impairment suggests the resulting COVID-19 disease is more likely to be mild to moderate, a potential early indicator that could help health care providers determine which patients may require hospitalization.
With increased awareness and fear of COVID-19, some patients have refrained from going to the Emergency Department, even when most needed. Doctors at UC San Diego Health wish to reassure the public that fear of coronavirus should not deter patients…
Physicians and scientists at UC San Diego Health have launched a pair of serological tests that will look for novel coronavirus antibodies—evidence in persons tested that they have previously been infected by the viral cause of COVID-19, even if they never experienced tell-tale symptoms.
Recovery. Reentry. Reopen. Return. A new normal. Faculty experts at DePaul University are available for news media interviews about what comes next — after the COVID-19 pandemic. Does the world return to normal or will there be fundamental changes to how we live our lives, work, and travel; and how we are governed?
Researchers at UC San Diego Health publish the first empirical findings that strongly associate sensory loss and COVID-19, the respiratory disease caused by the novel coronavirus.
Researchers from Intermountain Healthcare and University of Utah Health in Salt Lake City have launched two vital clinical trials to test the effectiveness and safety of two drugs – hydroxychloroquine (HCQ) and azithromycin – to treat patients with COVID-19.
Who should be tested for the novel coronavirus that causes COVID-19? And what do the different types of tests actually measure? Jeffrey Bender, MD, a pediatric infectious disease specialist at Children’s Hospital Los Angeles, gives the latest update and explains what parents need to know.
The Johns Hopkins Bloomberg School of Public Health is launching the first in a series of press briefings at 2:30–3 p.m. EDT on Thursday, April 9.
CHICAGO – During the novel coronavirus COVID-19 pandemic, the Academy of Nutrition and Dietetics, the world’s largest organization of food and nutrition professionals, urges the U.S. Department of Health and Human Services to address crucial personal protective equipment shortages for frontline health care workers and those providing access to food security programs.
As the coronavirus continues to spread across the U.S. and worldwide, many are trying to better understand what the virus is and how it affects us. Yet, in the midst of the pandemic, misinformation has been spreading virally. University of…
Researchers at University of California San Diego School of Medicine are launching a pair of studies to answer critical questions regarding the roles COVID-19 may play in breast milk and pregnancy.
As more people turn to social media and other online sources for updates on the novel coronavirus outbreak, determining which sources are reliable becomes increasingly difficult. Experts Dana Coester and Bob Britten in the West Virginia University Reed College of…
West Virginia University is connecting patients, recently discharged from long-term care facilities, with medical professionals who can manage their healthcare remotely via technology. This telehealth approach may now prove to be a more versatile tool as the U.S. responds to the looming threat of the novel coronavirus.
With fears over the novel coronavirus shuttering the sports world, Brad Humphreys, economics professor at West Virginia University, said the long-term economic impact could be “substantial” and “uncertain.” Humphreys, whose area of expertise is the economics and financing of sports,…
Countries fighting outbreaks of the novel coronavirus disease COVID-19 should consider using the antibodies of people who have recovered from infection to treat cases and provide short-term immunity—lasting weeks to months—to critical health care workers, argue two infectious disease experts.
.ROCKVILLE, MD – As concern continues to grow concerning the novel coronavirus, COVID-19, so does the opportunity for misinformation to spread as the public searches for reliable information on infection and means of protection.